BTIG analyst Ryan Zimmerman reiterated a Neutral rating on Procept BioRobotics Corp (NASDAQ: PRCT).The analyst comments "We maintain our Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

PROCEPT BioRobotics Corporation (PRCT) Announces Proposed $175M Share OfferingOctober 28, 2024 4:19 PM PROCEPT BioRobotics Corporation Announces Proposed Offering of Common StockOctober 28, 2024 4:19 PM Form 424B5 PROCEPT BioRobotics Corp October 28, 2024 4:06 PM Form 10-Q PROCEPT BioRobotics Corp For: Sep 30October 28, 2024 4:01 PM PROCEPT BioRobotics Corporation (PRCT) November 70 and December 90 calls active as share price up 27%October 28, 2024 1:51 PM PROCEPT BioRobotics Corporation (PRCT) Tops Q3 EPS by 9cOctober 28, 2024 7:08 AM Form 8-K PROCEPT BioRobotics Corp For: Oct 28October 28, 2024 7:03 AM Deborah Kilpatrick Joins Sonder Capital as its Newest Venture PartnerOctober 28, 2024 7:00 AM PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA GuidanceOctober 28, 2024 7:00 AM